Barclays’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73M Sell
220,623
-1,938
-0.9% -$659K 0.03% 602
2025
Q4
$88.5M Buy
222,561
+128,153
+136% +$56.7M 0.04% 553
2025
Q3
$43.1M Buy
94,408
+350
+0.4% +$143K 0.02% 847
2025
Q2
$30.7M Sell
94,058
-1,661
-2% -$460K 0.01% 914
2025
Q1
$25.8M Sell
95,719
-8,128
-8% -$2.09M 0.01% 905
2024
Q4
$24.4M Sell
103,847
-1,338
-1% -$352K 0.01% 1014
2024
Q3
$28.9M Sell
105,185
-26,080
-20% -$6.79M 0.01% 894
2024
Q2
$31.9M Sell
131,265
-62,707
-32% -$9.9M 0.01% 773
2024
Q1
$29M Buy
193,972
+51,972
+37% +$8.67M 0.01% 836
2023
Q4
$27.2M Sell
142,000
-20,195
-12% -$3.44M 0.01% 928
2023
Q3
$28.7M Sell
162,195
-47,950
-23% -$9.15M 0.02% 659
2023
Q2
$39.9M Buy
210,145
+68,550
+48% +$13.6M 0.03% 523
2023
Q1
$28.4M Sell
141,595
-20,539
-13% -$4.32M 0.03% 703
2022
Q4
$38.5M Buy
162,134
+20,780
+15% +$4.43M 0.03% 602
2022
Q3
$28.3M Buy
141,354
+15,233
+12% +$2.91M 0.03% 490
2022
Q2
$18.4M Buy
126,121
+46,523
+58% +$6.6M 0.02% 763
2022
Q1
$13M Sell
79,598
-2,367
-3% -$361K 0.01% 829
2021
Q4
$13.9M Sell
81,965
-15,510
-16% -$2.88M 0.01% 1095
2021
Q3
$18.4M Sell
97,475
-5,551
-5% -$1.04M 0.01% 920
2021
Q2
$17.5M Buy
103,026
+25,161
+32% +$3.69M 0.01% 953
2021
Q1
$11M Buy
77,865
+14,890
+24% +$2.24M 0.01% 1046
2020
Q4
$8.19M Sell
62,975
-31,520
-33% -$4.21M 0.01% 1250
2020
Q3
$13.8M Sell
94,495
-21,693
-19% -$3.08M 0.02% 895
2020
Q2
$17.2M Buy
116,188
+13,473
+13% +$1.82M 0.03% 705
2020
Q1
$11.2M Buy
102,715
+41,557
+68% +$4.8M 0.02% 928
2019
Q4
$7.04M Sell
61,158
-39,729
-39% -$3.96M 0.01% 1680
2019
Q3
$8.11M Buy
100,887
+34,994
+53% +$2.77M 0.01% 1457
2019
Q2
$4.78M Buy
65,893
+15,770
+31% +$1.21M 0.01% 1903
2019
Q1
$4.68M Sell
50,123
-23,443
-32% -$1.96M 0.01% 1706
2018
Q4
$5.36M Buy
73,566
+3,892
+6% +$299K 0.01% 1551
2018
Q3
$6.1M Buy
69,674
+19,562
+39% +$1.97M 0.01% 1611
2018
Q2
$4.94M Buy
50,112
+33,094
+194% +$3.28M 0.01% 1736
2018
Q1
$2.03M Sell
17,018
-68,526
-80% -$8.83M ﹤0.01% 2443
2017
Q4
$10.9M Buy
85,544
+74,097
+647% +$9.31M 0.02% 1140
2017
Q3
$1.34M Sell
11,447
-42,875
-79% -$3.66M ﹤0.01% 2724
2017
Q2
$4.33M Buy
54,322
+3,689
+7% +$236K 0.01% 1578
2017
Q1
$2.6M Sell
50,633
-539
-1% -$24.9K 0.01% 1835
2016
Q4
$1.92M Buy
51,172
+33,285
+186% +$1.39M 0.01% 2161
2016
Q3
$1.21M Buy
17,887
+8,385
+88% +$592K ﹤0.01% 2444
2016
Q2
$527K Sell
9,502
-18,734
-66% -$1.18M ﹤0.01% 3167
2016
Q1
$1.75M Buy
28,236
+15,269
+118% +$1.02M 0.01% 2042
2015
Q4
$1.22M Sell
12,967
-26,166
-67% -$2.43M ﹤0.01% 2428
2015
Q3
$3.13M Buy
39,133
+26,649
+213% +$2.96M 0.01% 1736
2015
Q2
$1.49M Buy
12,484
+3,617
+41% +$432K ﹤0.01% 2497
2015
Q1
$922K Buy
8,867
+8,339
+1,579% +$845K ﹤0.01% 3061
2014
Q4
$51K Sell
528
-32,831
-98% -$3.04M ﹤0.01% 5692
2014
Q3
$2.6M Sell
33,359
-28,462
-46% -$1.84M ﹤0.01% 2420
2014
Q2
$3.89M Buy
61,821
+51,955
+527% +$3.09M 0.01% 1984
2014
Q1
$661K Sell
9,866
-18,099
-65% -$1.4M ﹤0.01% 3676
2013
Q4
$1.79M Buy
27,965
+19,987
+251% +$1.19M ﹤0.01% 2792
2013
Q3
$510K Sell
7,978
-35,234
-82% -$1.76M ﹤0.01% 4081
2013
Q2
$1.34M Buy
+43,212
New +$1.15M ﹤0.01% 3004

Other funds holding ALNY